These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 25695795

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Biodistribution and targeting properties of iron oxide nanoparticles for treatments of cancer and iron anemia disease.
    Alphandéry E.
    Nanotoxicology; 2019 Jun; 13(5):573-596. PubMed ID: 30938215
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. IONP-PLL: a novel non-viral vector for efficient gene delivery.
    Xiang JJ, Tang JQ, Zhu SG, Nie XM, Lu HB, Shen SR, Li XL, Tang K, Zhou M, Li GY.
    J Gene Med; 2003 Sep; 5(9):803-17. PubMed ID: 12950071
    [Abstract] [Full Text] [Related]

  • 6. HER2/neu antibody conjugated poly(amino acid)-coated iron oxide nanoparticles for breast cancer MR imaging.
    Yang HM, Park CW, Woo MA, Kim MI, Jo YM, Park HG, Kim JD.
    Biomacromolecules; 2010 Nov 08; 11(11):2866-72. PubMed ID: 20932000
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mechanism of poly-l-lysine-modified iron oxide nanoparticles uptake into cells.
    Li Z, Shuai C, Li X, Li X, Xiang J, Li G.
    J Biomed Mater Res A; 2013 Oct 08; 101(10):2846-50. PubMed ID: 23504952
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of active, passive and magnetic targeting to tumors of multifunctional paclitaxel/SPIO-loaded nanoparticles for tumor imaging and therapy.
    Schleich N, Po C, Jacobs D, Ucakar B, Gallez B, Danhier F, Préat V.
    J Control Release; 2014 Nov 28; 194():82-91. PubMed ID: 25178270
    [Abstract] [Full Text] [Related]

  • 15. Synthesis, characterization and in vitro evaluation of exquisite targeting SPIONs-PEG-HER in HER2+ human breast cancer cells.
    Almaki JH, Nasiri R, Idris A, Majid FA, Salouti M, Wong TS, Dabagh S, Marvibaigi M, Amini N.
    Nanotechnology; 2016 Mar 11; 27(10):105601. PubMed ID: 26861770
    [Abstract] [Full Text] [Related]

  • 16. Magnetic nanoparticle biodistribution following intratumoral administration.
    Giustini AJ, Ivkov R, Hoopes PJ.
    Nanotechnology; 2011 Aug 26; 22(34):345101. PubMed ID: 21795772
    [Abstract] [Full Text] [Related]

  • 17. Triple Therapy of HER2+ Cancer Using Radiolabeled Multifunctional Iron Oxide Nanoparticles and Alternating Magnetic Field.
    Zolata H, Afarideh H, Davani FA.
    Cancer Biother Radiopharm; 2016 Nov 26; 31(9):324-329. PubMed ID: 27831759
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hyaluronic acid-modified hydrothermally synthesized iron oxide nanoparticles for targeted tumor MR imaging.
    Li J, He Y, Sun W, Luo Y, Cai H, Pan Y, Shen M, Xia J, Shi X.
    Biomaterials; 2014 Apr 26; 35(11):3666-77. PubMed ID: 24462358
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.